Despite Vaccine, Public Should Not Get Complacent About Pneumococcal Disease
Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, said scientists at a meeting in Boston."We have a vaccine that has dramatically reduced the total burden of pneumococcal disease.
Discovery Of New Signal Pathway Important To Diabetes Research
Scientists at Karolinska Institutet and Miami University have discovered that cells in the pancreas cooperate - signal - in a way hitherto unknown. The discovery can eventually be of significance to the treatment of diabetes. The aim of the project was to find out how the healthy body regulates glucose concentrations in the blood.
Advancing Nanoparticle Technology Creating Opportunities For Drug Developers - Examining Technology, Therapeutic And Market Factors
Advances in nanotechnology that enable drugs to be delivered in ways that preserve their efficacy and to precise therapeutic targets are creating a host of opportunities for drug developers. A variety of nanostructures are being investigated as functional drug carriers for a wide range of therapies, most notably cardiovascular medicine, autoimmune diseases, and cancer.
Individual Differences, Density Dependence And Offspring Birth Traits In A Population Of Red Deer
Variation between individuals is the keystone of natural selection: without it, there could be no evolutionary change.
Parental Notification Initiative Certified For California's Ballot
An initiative that would require parental notification and a 48-hour waiting period before minors could receive abortions will be on California's Nov. 4 ballot, California Secretary of State Debra Bowen (D) announced Friday, the AP/San Jose Mercury News reports.
The GI Company Reports Significant Reduction In Occurrence Of Oral Mucositis In Phase II Study Presented At ASCO
The GI Company, Inc., a privately held developer of gastrointestinal therapeutics, presented final results of a Phase II clinical study designed to evaluate the safety and efficacy of the company's lead drug, Intestinal Trefoil Factor (rhITF) at the American Society of Clinical Oncology (ASCO) 2008 Annual Meeting.
Republican Lawmakers Criticize Specialty Hospital Amendment In Supplemental War Appropriations Bill
Four Republican lawmakers on Monday in a letter to the Senate Appropriations Committee criticized an amendment to a supplemental war appropriations bill (HR 2642) that would allow some physician-owned specialty hospitals to continue to participate in Medicare and Medicaid, CongressDaily reports (Edney, CongressDaily, 6/3).
Cold Spring Harbor Protocols Features Methods For Analyzing Genomes And Plant Cells
With the sequencing of the human genome came the startling revelation that the number of copies of a genes and other DNA sequences can vary widely between individuals. This Copy Number Variation (or CNV), contributes to our species' genetic diversity but it has also been linked to genetic diseases.
American Academy Of Sleep Medicine Blog Will Provide Live Updates Featuring The Latest News And Research From SLEEP 2008 In Baltimore
The American Academy of Sleep Medicine announced that it has launched a new blog at http://www.sleepmeeting.blogspot.com to give members, the media and the public live updates from the Baltimore Convention Center when the SLEEP 2008 22nd Annual Meeting of the Associated Professional Sleep Societies convenes from June 9 to 12.
Tuberculosis - MIT Creates New Testing And Reporting System, Rewarding Patients Who Take Their Medicine
One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medicine. MIT students have come up with a possible solution: a new testing and reporting system that is easy for patients to use and offers economic incentives such as free cell phone minutes.